Also trades as: PLX.TA (TLV) · $vol 0M
PLX AMEX
Protalix BioTherapeutics, Inc.
1W: -0.4%
1M: +4.6%
3M: +17.8%
YTD: +55.8%
1Y: +14.8%
3Y: +59.4%
5Y: +106.9%
$2.71
+0.03 (+1.12%)
Weekly Expected Move ±5.2%
$2
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$81M
Revenue
+30.1% YoY
$19M
Net Income
+201.9% YoY
$8M
Free Cash Flow
+322.6% YoY
61.0%
Gross Margin
23.5%
Op. Margin
19.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE31.2%
ROA20.1%
ROIC47.1%
Valuation
P/E11.2
P/B3.0
EV/EBITDA6.1
Leverage
Debt/Equity0.13
Current Ratio2.94
Interest Cov.19.8x
Quality Scores
Piotroski F5/9
Altman Z0.49
Beneish M-1.40